| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |